Abstract:Background: S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known about the clinical significance of S100A2 in endometrial carcinoma. Methods: Clinicopathological data were obtained from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Gene Expression Omnibus (GEO), and Clinical Proteomic Tumor Analysis Consortium (CPTAC). First, the expression and prognostic value of different S100 family members in endometrial carcinoma were evaluated. Subsequently, the Kaplan-Meier plotter and Cox regression analysis were used to assess the prognostic significance of S100A2, while the association between S100A2 expression and clinical characteristics in endometrial carcinoma was also analyzed using logistic regression. A receiver operating characteristic (ROC) curve and a nomogram were constructed. The putative underlying cellular mechanisms were explored using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene set enrichment analysis (GSEA). Results: Our results revealed that S100A2 expression was significantly higher in endometrial carcinoma tissue than in non-cancerous tissue at both the mRNA and protein levels. Analysis of Kaplan-Meier plotter data revealed that patients with high S100A2 expression had shorter overall survival (OS) and disease specific survival (DSS) compared with those of patients with low S100A2 expression. Multivariate Cox analysis further confirmed that high S100A2 expression was an independent risk factor for OS in patients with endometrial carcinoma. Other clinicopathologic features found to be related to worse prognosis in endometrial carcinoma included age, clinical stage, histologic grade, and tumor invasion. Importantly, ROC analysis also confirmed that S100A2 has a high diagnostic value in endometrial carcinoma. KEGG enrichment analysis and GSEA revealed that the estrogen and IL-17 signaling pathways were significantly upregulated in the high S100A2 expression group, in which estrogen response, JAK-STAT3, K-Ras, and TNFα/NF-κB were differentially enriched. Conclusions: S100A2 plays an important role in endometrial carcinoma progression and may represent an independent diagnostic and prognostic biomarker for endometrial carcinoma.

Nuclear Expression of S100a4 is Associated with Aggressive Behavior of Epithelial Ovarian Carcinoma: an Important Autocrine/Paracrine Factor in Tumor Progression

Expression of Octamer-4 in Serous and Mucinous Ovarian Carcinoma.

Stage-Specific Embryonic Antigen 4 Expression In Epithelial Ovarian Carcinoma

S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.

Expression of Sox2 in Human Ovarian Epithelial Carcinoma.

[Nuclear Expression of S100A4 is Associated with Lymph Node Metastasis in Gastric Carcinoma].

Expressions of S100A4 in lung cancer tissues and its clinical significance

Different expression of S 100 A 11 in normal ovarian epithelium , serous benign / borderline tumor , and low-grade serous ovarian carcinoma

High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

Expression of S100A11 is a Prognostic Factor for Disease-free Survival and Overall Survival in Patients With High-grade Serous Ovarian Cancer.

Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma

Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy

Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases

[Correlations of S100A4 Protein Expression to Invasion and Metastasis of Non-Small Cell Lung Cancer].

The Expression of S100P Increases and Promotes Cellular Proliferation by Increasing Nuclear Translocation of Β-Catenin in Endometrial Cancer.

S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the "MELF" pattern

Expression of S100A4 and matrix metalloproteinase 2 and their correlations with clinicopathological features in esophageal squamous cell carcinoma

S100A1 overexpression stimulates cell proliferation and is predictive of poor outcome in ovarian cancer

Abstract 1891: Annexin A2-binding S100 proteins promote proliferation and cell cycle progression of EGFR positive cancer cells

S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior In Vitro and In Vivo of Cervical Cancer

Expression of KISS1 and S100A4 in Gastric Carcinoma and the Correlation with Metastasis